France Inflammatory Bowel Disease Treatment Market Size & Outlook
France inflammatory bowel disease treatment market, 2018-2030 (US$M)
Related Markets
France inflammatory bowel disease treatment market highlights
- The France inflammatory bowel disease treatment market generated a revenue of USD 599.8 million in 2023 and is expected to reach USD 848.5 million by 2030.
- The France market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, crohn's disease was the largest revenue generating type in 2023.
- Ulcerative Colitis is the most lucrative type segment registering the fastest growth during the forecast period.
Inflammatory bowel disease treatment market data book summary
| Market revenue in 2023 | USD 599.8 million |
| Market revenue in 2030 | USD 848.5 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Crohn's disease |
| Fastest growing segment | Ulcerative Colitis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Crohn's Disease, Ulcerative Colitis |
| Key market players worldwide | AbbVie Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Biogen Inc, Novartis AG ADR, Eli Lilly and Co, UCB SA, Merck & Co Inc, Johnson & Johnson, Celltrion Healthcare |
Other key industry trends
- In terms of revenue, France accounted for 2.9% of the global inflammatory bowel disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany inflammatory bowel disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 65.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inflammatory Bowel Disease Treatment Market Scope
Inflammatory Bowel Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France inflammatory bowel disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inflammatory bowel disease treatment market will help companies and investors design strategic landscapes.
Crohn's disease was the largest segment with a revenue share of 60.17% in 2023. Horizon Databook has segmented the France inflammatory bowel disease treatment market based on crohn's disease, ulcerative colitis covering the revenue growth of each sub-segment from 2018 to 2030.
Furthermore, the France inflammatory bowel disease treatment market is mainly driven by the increasing prevalence of the disease and growing awareness about early diagnosis & treatment among people. For instance, the estimated number of IBD in France was 505,822 in 2020, and it is expected to reach 695,090 by 2030.
Moreover, increasing approval of cost-effective biosimilars in the country is anticipated to increase the prescription rate of biosimilars for the treatment of IBD. Moreover, the presence of local companies involved in development of novel treatments for IBD is anticipated to fuel the market.
For instance, in November 2019, ABIVAX received ANSM approval for ABX464-103 to conduct phase IIB clinical trials in 15 countries. Numerous clinical trials being conducted in various countries are anticipated to ease the marketing authorization process and help expand the reach of products in newer markets.
Reasons to subscribe to France inflammatory bowel disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France inflammatory bowel disease treatment market databook
-
Our clientele includes a mix of inflammatory bowel disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France inflammatory bowel disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into France inflammatory bowel disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France inflammatory bowel disease treatment market size, by type, 2018-2030 (US$M)
France Inflammatory Bowel Disease Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
